Generated by AI
Harrow Inc. is an eyecare pharmaceutical company that develops, manufactures, and commercializes ophthalmic products for the U.S. market. Its portfolio includes prescription and non-prescription therapies used by eye care professionals to manage conditions affecting the front and back of the eye, such as dry eye disease, glaucoma, cataracts, retinal disorders, allergies, and infections. Harrow operates through branded pharmaceuticals and ImprimisRx, its ophthalmology-focused compounding business, giving it a broad commercial footprint across eye care settings. The company’s products are used in physician offices, clinics, and surgical environments, supporting routine treatment as well as specialized ophthalmic care. Headquartered in Nashville, Tennessee, Harrow focuses on accessible eye care solutions and a product mix that spans branded, compounded, and other ophthalmic formulations.
Website1A Burton Hills Boulevard
Nashville, TN, 37215
United States
The latest articles about HROW.
Detailed price information for Harrow Inc (HROW-Q) from The Globe and Mail including charting and trades.
Tipranks Press Release.
Summary of Nov 10's posts. Generated by AI.
Summary of Aug 11's posts. Generated by AI.
Summary of Nov 10's posts. Generated by AI.
Summary of Nov 11's posts. Generated by AI.
Investors talking about HROW also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.